Sildenafil Tablet, Film Coated
Product Images NDC 50090-5236

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-5236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
This text appears to be a chart listing various drugs, with recommendations for their use in combination with Sildenafil, including fold change and 90% Confidence Interval (CI) recommendations. Some drugs require no dose adjustment, while others are not recommended for co-administration with Sildenafil. The text also includes some additional symbols and numbers which may represent more specific information or data points.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
This is a list of drugs and their interaction with Acenocoumarol. It provides recommendations for dose adjustment and co-administration with the interacting drugs. The text also includes information on the effect of certain drugs on INR AUC, BT, and Cmax. Additionally, it provides fold change and 90% CI information relevant to the interacting drugs, as well as recommendations for dose adjustment for certain drugs.*
FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

FDA Label Image

Structure (Structure)

FDA Label Image

Camber1 (Camber1)

FDA Label Image

Camber2 (Camber2)

FDA Label Image

Image1 (Image1)

Image1 (Image1)
This appears to be a graph depicting the mean change from baseline in meters for different treatments over the course of a study up to week 12. The treatments include B—a—a EHildenaflil 1mg TID, Sildenafil Smg TID, and Eildenalil 20mg TID. Each treatment is represented by a line on the graph and the Standard Error is also shown.*
FDA Label Image

Label Image (Lbl500905236)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.